Multiple Sclerosis Drugs: Next Generation Ifn-Beta
Stomach Cancer Drugs
Head And Neck Cancer Drugs
Perpetual Pharmaceutical Pearl Provider, Abion
Abion is the company specializing in the development of innovative companion diagnostics-based new drugs that target the best-in-class / first-in-class categories of the global market.
Multiple sclerosis drugs (ABN101)
Multiple sclerosis is a nonfatal but incurable disease that causes great suffering for an extended period of time.
ABN 101 is an interferon-beta agent manufactured as a new protein drug, and it effectively increases patient convenience due to its reasonable price resulting from an improvement in productivity as well as the improvement in the side effects patients experience.
Stomach cancer drugs (ABN401)
Stomach cancer has the fifth highest incidence rate and the third highest mortality in the world.
ABN 401 is a candidate drug to treat stomach cancer due to abnormal kinase activation by efficiently inhibiting the activity of c-Met as a c-Met inhibitor.
Head and neck cancer drugs (ABN301)
The expression of the carcinogenic genes of Human Papilloma Virus (HPV) results in variety of cancers, such as head and neck cancer, cervical cancer, and genital cancer.
ABN 301 is a new drug that cures cancer by simultaneously inhibiting the expression of the E6/E7 genes of HPV as a nucleic acid agent, and it can maximize its effectiveness by combined prescription with chemotherapy and radiation therapy.